GlassScriptPhysician profile
Darlene S Johnson
NPI 1821080391
$3,694.20
in general payments reported to CMS, 2019-2025
28 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $520 · 2020: $365 · 2021: $380 · 2022: $492 · 2023: $642 · 2024: $943 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,936.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $472.12 | 2020-2025 | |
| Genzyme Corporation | $441.09 | 2021-2025 | |
| Lilly USA, LLC | $385.14 | 2019-2024 | Olumiant, Taltz, Ebglyss |
| Amgen INC. | $328.49 | 2019-2025 | Otezla, Otezla |
| Leo Pharma INC. | $314.92 | 2019-2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $267.13 | 2019-2025 | Levulan Kerastick, Winlevi |
| Regeneron Healthcare Solutions, INC. | $261.88 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $241.21 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $178.98 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $143.61 | 2022-2023 | Sotyktu |
| Dermavant Sciences, INC. | $117.56 | 2024 | Vtama |
| Strata Skin Sciences, INC. | $77.34 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.17 | 2021-2023 | Jublia |
| Incyte Corporation | $49.42 | 2021-2024 | Opzelura |
| Ucb, INC. | $48.62 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $37.75 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pfizer INC. | $33.57 | 2023 | |
| Organogenesis INC. | $26.89 | 2023 | Puraply |
| Convatec INC. | $26.20 | 2024 | |
| Almirall LLC | $25.15 | 2022 | |
| Mallinckrodt Hospital Products INC. | $24.54 | 2024 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.32 | 2024 | Spevigo |
| Allergan, INC. | $22.05 | 2021 | |
| Vyne Pharmaceuticals INC. | $18.65 | 2020 | |
| Aclaris Therapeutics, INC. | $17.16 | 2019 | |
| Dermira, INC. | $17.09 | 2019 | |
| Acera Surgical, INC. | $16.47 | 2022 | |
| Mayne Pharma Commercial LLC | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darlene Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.